In an effort to identify crucial biomarkers for pancreatic cancer prognosis, a study discovered a total of four genes, ACSL5, SLC44A4, LOX, and TOX3, showing correlation with PFS as indicated by qPCR and immunohistochemical staining. The gene discussed is ACSL5; the disease is familial pancreatic carcinoma.